Table 4. Confirmed diagnoses.
| Clusters | Subscales | ||||
| I | II | III | IV | Firsta | |
| Females | |||||
| Asthma | 8.0% | 11% | 9.5% | 7.1% | |
| Allergic rhinitis* | 26% | 29% | 27% | 19% | |
| Eczema* | 38% | 34% | 38% | 30% | |
| Allergic eye symptoms | 20% | 22% | 21% | 16% | |
| Hypertension | 13% | 14% | 13% | 15% | |
| Diabetes | 2.2% | 1.8% | 1.8% | 1.8% | |
| Thyroiditis | 3.0% | 3.0% | 2.3% | 1.8% | |
| Gastric ulcer | 1.3% | 1.4% | 2.7% | 2.1% | |
| Epilepsy | 0.6% | 2.2% | 1.2% | 1.4% | |
| Migraine | 17% | 21% | 20% | 20% | |
| Other neurologic disease | 0.7% | 0.2% | 1.1% | 1.6% | |
| Rheumatoid arthritis* | 1.3% | 0.6% | 1.4% | 3.0% | |
| Other arthritic condition | 4.7% | 5.6% | 5.7% | 4.4% | |
| Degenerative or other back condition | 14% | 15% | 12% | 13% | |
| Schizophrenia* | 0.4% | 1.2% | 1.6% | 3.0% | |
| Depression *** | 2.4% | 3.6% | 3.7% | 8.5% | HA4 |
| Males | |||||
| Asthma* | 7.7% | 13% | 7.2% | 7.9% | |
| Allergic rhinitis | 20% | 19% | 17% | 22% | |
| Eczema | 24% | 24% | 21% | 23% | |
| Allergic eye symptoms | 17% | 14% | 13% | 14% | |
| Hypertension* | 9% | 12% | 10% | 15% | |
| Diabetes | 0.2% | 0.0% | 0.8% | 0.8% | |
| Thyroiditis | 0.2% | 1.3% | 0.4% | 0.8% | |
| Gastric ulcer | 2.2% | 2.6% | 2.5% | 3.4% | |
| Epilepsy | 0.9% | 0.8% | 0.8% | 2.6% | |
| Migraine | 6.0% | 6.0% | 7.0% | 7.9% | |
| Other neurologic disease | 0.2% | 0.3% | 1.0% | 1.1% | |
| Rheumatoid arthritis | 0.7% | 0.3% | 0.8% | 0.3% | |
| Other arthritic condition | 4.7% | 5.7% | 5.8% | 2.9% | |
| Degenerative or other back condition | 17% | 20% | 19% | 16% | |
| Schizophrenia** | 0.9% | 1.3% | 2.0% | 3.7% | |
| Depression*** | 1.1% | 2.1% | 2.1% | 5.5% | HA4 |
*
p<0.05 uncorrected.
**
p<0.05 corrected.
***
p<0.01 corrected.
a
First scale: the individual TCI scale with the strongest significant association to the diagnosis. For significant associations between clusters and diagnoses, the values for the cluster with the highest percentage are in bold.